Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Common Equity (2016 - 2025)

Metlife has reported Common Equity over the past 17 years, most recently at $28.7 billion for Q4 2025.

  • Quarterly results put Common Equity at $28.7 billion for Q4 2025, up 3.53% from a year ago — trailing twelve months through Dec 2025 was $28.7 billion (up 3.53% YoY), and the annual figure for FY2025 was $28.7 billion, up 3.53%.
  • Common Equity for Q4 2025 was $28.7 billion at Metlife, down from $29.2 billion in the prior quarter.
  • Over the last five years, Common Equity for MET-PF hit a ceiling of $69.4 billion in Q2 2021 and a floor of $25.9 billion in Q3 2023.
  • Median Common Equity over the past 5 years was $30.2 billion (2022), compared with a mean of $37.0 billion.
  • Biggest five-year swings in Common Equity: tumbled 57.25% in 2022 and later grew 20.35% in 2024.
  • Metlife's Common Equity stood at $50.0 billion in 2021, then crashed by 39.77% to $30.1 billion in 2022, then rose by 0.42% to $30.3 billion in 2023, then fell by 8.43% to $27.7 billion in 2024, then increased by 3.53% to $28.7 billion in 2025.
  • The last three reported values for Common Equity were $28.7 billion (Q4 2025), $29.2 billion (Q3 2025), and $27.9 billion (Q2 2025) per Business Quant data.